Summary
We have investigated the effect of long-term strict glycaemic control on peripheral and autonomic nerve function in 45 IDDM patients (age 18–42 years, diabetes duration 7–23 years) without clinical signs of neuropathy or other neurological disease. They were randomly assigned to treatment either with continuous insulin infusion, multiple injections (4–6 times daily), or conventional treatment (twice daily) for 4 years and followed prospectively for 8 years. Motor and sensory nerve conduction velocities were measured at the start and after 8 years. Autonomic nerve function tests were performed only once, after 8 years. A significant reduction of nerve conduction velocity was observed during 8 years in patients with mean HbA1 more than 10% (n=12, group mean 10.9%, range 10.1–13.2%) compared to patients with HbA1 less than 10% (n=33, group mean 9.0%, range 7.5–9.9%). Change of motor nerve conduction velocity in the peroneal nerve was: −4.8±4.9 (SD) vs −2.2±5.3 m/s (p<0.01). Change of motor nerve conduction velocity in the posterior tibial nerve was: −6.8±5.7 vs −3.9±5.1 m/s (p<0.05). No significant changes were observed in the ulnar nerve. Change of sensoric nerve conduction velocity in the sural nerve was: −8.9±8.0 vs −4.6±5.3 m/s (p<0.05). Multiple regression analysis showed that a change in HbA1 of 1% resulted in a 1.3 m/s change in nerve conduction velocity during 8 years. A significantly lowered heart-rate variation during deep breathing (p<0.05) and heart-rate response to standing (p<0.01) was found in patients with HbA1 more than 10% compared to patients with HbA1 less than 10%. This study confirms that the long-term lowering of blood glucose retards the deterioration in nerve conduction velocity observed in the diabetic nerve.
Article PDF
Similar content being viewed by others
Abbreviations
- IDDM:
-
Insulin-dependent diabetes mellitus
References
Brown MJ, Ashbury AK (1984) Diabetic neuropathy. Ann Neurol 15: 2–12
Brown MJ, Greene DA (1984) Diabetic neuropathy: pathophysiology and management. In: Asbury AK, Gilliat RW (eds) Peripheral nerve disorders. Butterworth & Co, London, pp 126–153
Thomas PK, Eliassen SG (1984) Diabetic neuropathy. In: Dyck PJ, Thomas PK, Lambert EH, Bunge R (eds) Peripheral neuropathy. 2nd edn. Saunders, Philadelphia, pp 1773–1810
Boulton AJM, Worth RC, Druru J et al. (1984) Genetic and metabolic studies in diabetic neuropathy. Diabetologia 26: 15–19
Pirart J (1987) Diabetes mellitus and its degenerative complications: prospective study of 4400 patients observed between 1947 and 1973. Diabetes Care 1: 168–188
Dahl-Jørgensen K, Bjøro T, Kjerulf P, Sandvik L, Bangstad HJ, Hanssen KF (1992) The effect of long term strict glycemic control on kidney function in insulin-dependent diabetes mellitus: seven year results from the Oslo Study. Kidney Int 41: 920–923
Brinchmann-Hansen O, Dahl-Jørgensen K, Sandvik L, Hanssen KF (1992) Blood glucose concentrations and progression of diabetic retinopathy: the seven year results of the Oslo study. BMJ 304: 19–22
Hanssen KF, Bangstad H-J, Brinchmann-Hansen O, Dahl-Jørgensen K (1992) Blood glucose control and diabetic microvascular complications: long-term effects of near-normoglycaemia. Diabetic Med 9: 697–705
Reichard P, Berglund B, Britz A, Cars I, Nilsson BY, Rosenqvist U (1991) Intensified conventional insulin-treatment retards the microvascular complications of insulin-dependent diabetes mellitus (IDDM): the Stockholm Diabetes Intervention Study (SDIS) after 5 years. J Intern Med 230: 101–108
Unger RH (1982) Meticulous control of diabetes: benefits, risks, and precautions. Diabetes 31: 479–483
Committee on Health Care Issues (1986) Does improved control of glycemia prevent or ameliorate diabetic polyneuropathy ? Ann Neurol 19: 288–290
Ward JD, Barnes CG, Fisher DJ, Baker RW (1971) Improvement in nerve conduction following treatment in newly diagnosed diabetics. Lancet 1:428–430
Halar EM, Graf RJ, Halter JB, Brozovich FV, Soine TL (1982) Diabetic neuropathy: a clinical, laboratory and electrodiagnostic study. Arch Phys Med Rehabil 63: 298–303
Holman RR, Dornan TL, Mayon-White V et al. (1983) Prevention of deterioration of renal and sensory-nerve function by more intensive management of insulin-dependent diabetic patients: a two-year randomised prospective study. Lancet I: 204–208
Fedele D, Negrin P, Cardone C et al. (1984) Influence of continuous subcutaneous insulin infusion (CSSI) treatment on diabetic somatic and autonomic neuropathy. J Endocrinol Invest 7: 623–628
Service FJ, Rizza RA, Daube JR, O'Brien PC, Dyck PJ (1985) Near normoglycaemia improved nerve conduction and vibration sensation in diabetic neuropathy. Diabetologia 28: 722–727
Ehle AL, Raskin P (1986) Increased nerve conduction in diabetics after a year of improved glucoregulation. J Neurol Sci 74: 191–197
Warnmoltz JR, Mendell JR, O'Dorisio TM, Cataland S (1987) Comparison of the effects of continuous subcutaneous infusion and split-mixed injection of insulin on nerve function type I diabetes mellitus. J Neurol Sci 82: 161–169
Dahl-Jørgensen K, Brinchmann-Hansen O, Hanssen KF et al. (1986) Effect of near normoglycaemia for two years on progression of early diabetic retinopathy, nephropathy, and neuropathy: the Oslo study. BMJ 293: 1195–1199
Ewing DJ, Clarke BF (1982) Diagnosis and management of diabetic autonomie neuropathy. BMJ 285: 916–918
Veves A, Malik RA, Lye RH et al. (1991) The relationship between sural nerve morphometric findings and measures of peripheral nerve function in mild diabetic neuropathy. Diabetic Med 8: 917–921
Mc Culloch DK, Campbell IW, Prescott RJ, Clarke BF (1980) Effect of alcohol intake on symptomatic peripheral neuropathy in diabetic men. Diabetes Care 3: 245–247
Dyck PJ, O'Brien PC (1989) Meaningful degrees of prevention or improvement of nerve conduction in controlled clinical trials of diabetic neuropathy. Diabetes Care 12: 649–652
Young RR, Shahani BT (1978) Clinical value and limitation of F-wave determination. Muscle Nerve 1: 248–249
Behse F, Buchtal F, Carlsen F (1977) Nerve biopsy and conduction studies in diabetic neuropathy. J Neurol Neurosurg Psych 40: 1072–1082
Dyck PJ, Sherman WR, Hallcher LM et al. (1980) Human diabetic endoneurial sorbitol, fructose, and myo-inositol related to sural nerve morphometry. Ann Neurol 8: 590–596
Sima AAF, Brismar T (1985) Reversible diabetic nerve dysfunction: structural correlates to electrophysiological abnormalities. Ann Neurol 18: 21–29
Gregersen G (1986) Variation in motor conduction velocities produced by acute changes in the metabolic state in diabetic patients. Diabetologia 4: 273–277
Gregersen G (1967) Diabetic neuropathy: influence of age, sex, metabolic control, and duration of diabetes on motor conduction velocity. Neurology 17: 972–979
Boulton AJM, Drury J, Clarke B, Ward JD (1982) Continuous subcutaneous insulin infusion in the management of painful diabetic neuropathy. Diabetes Care 5: 386–390
Pietri A, Ehle Al, Raskin P (1980) Changes in nerve conduction velocity after six weeks of glucoregulation with portable insulin infusion pumps. Diabetes 29: 668–671
Gambardella S, Napoli A, Spallone V et al. (1983) Influence of glucoregulation with continuous subcutaneous insulin infusion on nerve conduction velocity and beat to beat variation in diabetics. J Endocrinol Invest 6: 363–367
Warnmoltz JS, Mendell JR, O'Dorisio TM, Catland S (1981) Evaluation of portable infusion pump on peripheral nerve function in diabetes mellitus. Neurology 31: 129–133
Hamet P, Abarca G, Lopez D et al. (1982) Patient self-management of continuous subcutaneous insulin infusion. Diabetes Care 5: 485–491
Dahl-Jørgensen K (1987) Near normoglycemia and late diabetic complications. The Oslo study (Thesis). Acta Endocrinol [Suppl 284]
Reichard P, Nilsson B-Y, Rosenqvist U (1993) The effect of long-term intensified insulin treatment on the development of microvascular complications of diabetes mellitus. N Engl J Med 329: 304–309
The Diabetes Control and Complications Trial Research Group (1993) The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med 329: 977–986
O'Brien IAD, O'Hare JP, Lewin IG, Corrall RJM (1986) The prevalence of autonomic neuropathy in insulin-dependent diabetes mellitus: a controlled study based on heart rate variability. Q J Med 61: 951–967
Jakobsen J, Christiansen JS, Kristoffersen J et al. (1988) Autonomic and somatosensory nerve function after 2 years of continuous subcutaneous insulin infusion in type I diabetes. Diabetes 37: 452–455
Malik RA, Newrick PG, Sharma AK et al. (1989) Microangiopathy in human diabetic neuropathy: relationship betweeen capillary abnormalities and the severity of neuropathy. Diabetologia 32: 92–102
Tesfaye S, Harris ND, Wilson RM, Ward JD (1992) Exerciseinduced conduction velocity increment: a marker of impaired peripheral nerve blood flow in diabetic neuropathy. Diabetologia 35: 155–159
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Amthor, K.F., Dahl-Jørgensen, K., Berg, T.J. et al. The effect of 8 years of strict glycaemic control on peripheral nerve function in IDDM patients: the Oslo study. Diabetologia 37, 579–584 (1994). https://doi.org/10.1007/BF00403376
Received:
Revised:
Issue Date:
DOI: https://doi.org/10.1007/BF00403376